Breaking News

FLAMMA Acquires Teva’s Philadelphia cGMP Facility

Marks entry into the U.S. marketplace with labs & pilot plant

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Flamma SpA, a contract development and manufacturing organization (CDMO) that develops, manufactures, and commercializes small molecule active pharmaceutical ingredients (APIs) for the pharmaceutical industry, has acquired Teva’s Chemical Synthesis Center in Malvern, PA in the Philadelphia area.   “The industry knows and respects the Flamma brand, yet some customers are apprehensive when considering the placement of a project overseas. Flamma understands this and feels that this will be a good o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters